Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Achan, Jane ^a   Talisuna, Ambrose O ^a   Erhart, Annette ^b   Yeka, Adoke ^c   Tibenderana, James K ^d   Baliraine, Frederick N ^e   Rosenthal, Philip J ^e   D'Alessandro, Umberto ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c Uganda Malaria Surveillance Project   (Uganda)

^d MALARIA CONSORTIUM   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CLINDAMYCIN; DOXYCYCLINE; MEFLOQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TETRACYCLINE; ANTIMALARIAL AGENT;

ABDOMINAL PAIN; ASTHMA; DIARRHEA; DISEASE SEVERITY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG ELIMINATION; DRUG QUALITY; DRUG SAFETY; DRUG TREATMENT FAILURE; FIRST TRIMESTER PREGNANCY; HEADACHE; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGLYCEMIA; HYPOTENSION; LIVER INJURY; MALARIA; MALARIA FALCIPARUM; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PSYCHOSIS; RASH; REVIEW; RISK ASSESSMENT; THROMBOCYTOPENIA; TINNITUS; TREATMENT OUTCOME; TUBERCULOSIS; VEIN THROMBOSIS; VERTIGO; VISUAL IMPAIRMENT; VOMITING; HISTORY;

ANTIMALARIALS; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MALARIA; QUININE;

EID: 79956282726     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-144     Document Type: Review

References (109)

1. How Was Quinine Discovered? http://www.ehow.com/facts-5828007-quinine- discovered-.html#ixzz1JrTqGgQq
2. Encyclopedia of Family Health. B David RMY Jacoby, Third 2005
3. Quinine. http://www.discoveriesinmedicine.com/Ni-Ra/Quinine.html
4. Cinchona bark. http://historyofmalaria.com/2010/02/cinchona-bark/
5. The history of antimalarial drugs. SMaM Dobson, Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery Totowa, New Jersey: Humana Press, PJ R, 2001 15 25
6. Handbook of Drugs for Tropical Parasitic Infections. OE Yakoub AdenAbdi Lars L Gustafsson Orjan Ericsson Hellgren Urban, 2 1995
7. Some notes on the Cinchona Industry. H BF, Chemical News 1931 142 129 133
8. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans. LA Salako A Sowunmi, Eur J Clin Pharmacol 1992 42 2 171 174 10.1007/BF00278479 1618248
9. Differences in the binding of quinine and quinidine to plasma proteins. GW Mihaly MS Ching MB Klejn J Paull RA Smallwood, Br J Clin Pharmacol 1987 24 6 769 774 3440096 (Pubitemid 18078380)
10. The treatment of malaria. NJ White, N Engl J Med 1996 335 11 800 806 10.1056/NEJM199609123351107 8703186 (Pubitemid 26296541)
11. Chemotherapy of parasitic infections. Tracy. WLaJ. e, Goodman and Gilman's Pharmacological basis of therapeutics, Alfred Goodman Gilman LEL JGH, 9 7 978 981 21204365
12. Rectal dihydroartemisinin versus intravenous quinine in the treatment of severe malaria: a randomised clinical trial. F Esamai P Ayuo W Owino-Ongor J Rotich A Ngindu A Obala F Ogaro L Quoqiao G Xingbo L Guangqian, East Afr Med J 2000 77 5 273 278 12858920 (Pubitemid 33209341)
13. Single-dose comparative kinetics and bioavailability study of quinine hydrochloride, quinidine sulfate and quinidine bisulfate sustained-release in healthy male volunteers. A Jamaludin M Mohamed V Navaratnam N Mohamed E Yeoh W Wernsdorfer, Acta Leiden 1988 57 1 39 46 3245401
14. Quinine disposition kinetics. NJ White P Chanthavanich S Krishna C Bunch K Silamut, Br J Clin Pharmacol 1983 16 4 399 403 6626434 (Pubitemid 13015764)
15. Antimalarial pharmacokinetics and treatment regimens. NJ White, Br J Clin Pharmacol 1992 34 1 1 10 1633062
16. Severe and complicated malaria. WHO, Trans R Soc Trop Med Hyg 2000 94 Suppl 1 1 90 10748883
17. Audiometry as a possible indicator of quinine plasma concentration during treatment of malaria. KK Karlsson U Hellgren G Alvan L Rombo, Trans R Soc Trop Med Hyg 1990 84 6 765 767 10.1016/0035-9203(90)90069-Q 2096500
18. High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. W Okitolonda C Delacollette M Malengreau JC Henquin, Br Med J (Clin Res Ed) 1987 295 6600 716 718 10.1136/bmj.295.6600. 716 (Pubitemid 17137942)
19. Quinine and severe falciparum malaria in late pregnancy. S Looareesuwan RE Phillips NJ White S Kietinun J Karbwang C Rackow RC Turner DA Warrell, Lancet 1985 2 8445 4 8 2861481
20. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. A Dondorp F Nosten K Stepniewska N Day N White, Lancet 2005 366 9487 717 725 16125588 (Pubitemid 41207233)
21. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. AM Dondorp CI Fanello IC Hendriksen E Gomes A Seni KD Chhaganlal K Bojang R Olaosebikan N Anunobi K Maitland E Kivaya T Agbenyega SB Nguah J Evans S Gesase C Kahabuka G Mtove B Nadjm J Deen J Mwanga-Amumpaire M Nansumba C Karema N Umulisa A Uwimana OA Mokuolu OT Adedoyin WB Johnson AK Tshefu MA Onyamboko T Sakulthaew WP Ngum K Silamut K Stepniewska CJ Woodrow D Bethell B Wills M Oneko TE Peto L von Seidlein NP Day NJ White AQUAMAT group, Lancet 376 9753 1647 1657
22. Antimalarial Martindale, The Extra Pharmacopoeia. London: Pharmaceuitical Press 30 1993
23. Malaria treatment guidelines. WHO, 2010
24. Global antimalarial drug policies database - WHO African region. WHO, 2009 September edn
25. Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon. C Sayang M Gausseres N Vernazza-Licht D Malvy D Bley P Millet, Malar J 2009 8 174 10.1186/1475-2875-8-174 19640283
26. UMSP sentinel site malaria surveillance report July 2010. (UMSP) UMSP, 2010
27. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? A Yeka J Achan U D'Alessandro AO Talisuna, Lancet Infect Dis 2009 9 7 448 452 10.1016/S1473-3099(09)70109-4 19555904
28. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. B Wasunna D Zurovac CA Goodman RW Snow, Malar J 2008 7 29 10.1186/1475-2875-7-29 18252000
29. In vivo and in vitro responses to quinine and quinidine of Plasmodium falciparum. A Sabchareon T Chongsuphajaisiddhi V Sinhasivanon P Chanthavanich P Attanath, Bull World Health Organ 1988 66 3 347 352 3048758
30. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border. SR Meek EB Doberstyn BA Gauzere C Thanapanich E Nordlander S Phuphaisan, Am J Trop Med Hyg 1986 35 2 246 250 3513642 (Pubitemid 16055386)
31. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. JM de Souza UK Sheth RM de Oliveira H Roulet SD de Souza, Bull World Health Organ 1985 63 3 603 609 3899397 (Pubitemid 16237131)
32. Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand. W Fungladda ER Honrado K Thimasarn D Kitayaporn J Karbwang P Kamolratanakul R Masngammueng, Bull World Health Organ 1998 76 Suppl 1 59 66 9763724 (Pubitemid 128685315)
33. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. S Pukrittayakamee A Chantra S Vanijanonta R Clemens S Looareesuwan NJ White, Antimicrob Agents Chemother 2000 44 9 2395 2398 10.1128/AAC.44.9.2395-2398.2000 10952585 (Pubitemid 30650885)
34. Randomised trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated falciparum malaria. S Looareesuwan S Vanijanonta C Viravan P Wilairatana P Charoenlarp R Lasserre C Canfield DE Kyle HK Webster, Acta Trop 1994 57 1 47 53 10.1016/0001-706X(94)90092-2 7942354 (Pubitemid 24229934)
35. Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. PJBN de Vries H Van Thien LN Hung TK Anh PA Kager SH Heisterkamp, Antimicrob Agents Chemother 2000 44 5 1302 1308 10.1128/AAC.44.5.1302-1308.2000 10770766 (Pubitemid 30228309)
36. Drug resistant malaria with special reference to chemotherapy. TBD Harinasuta, Mosquito-Borne Diseases Bulletin 1984 1 23-30
37. Comparison of 3, 5 and 7 days' treatment with Quinimax for falciparum malaria in Guinea-Bissau. PE Kofoed E Mapaba F Lopes F Pussick P Aaby L Rombo, Trans R Soc Trop Med Hyg 1997 91 4 462 464 10.1016/S0035-9203(97)90286-8 9373656 (Pubitemid 27421244)
38. Reducing the oral quinine-quinidine-cinchonin (Quinimax) treatment of uncomplicated malaria to three days does not increase the recurrence of attacks among children living in a highly endemic area of Senegal. C Rogier R Brau A Tall B Cisse JF Trape, Trans R Soc Trop Med Hyg 1996 90 2 175 178 10.1016/S0035-9203(96)90128-5 8761582 (Pubitemid 26141090)
39. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. PG Kremsner S Winkler C Brandts S Neifer U Bienzle W Graninger, J Infect Dis 1994 169 2 467 470 10.1093/infdis/169.2.467 8106787 (Pubitemid 24045618)
40. Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands. GOP Di Perri S Nardi R Deganello B Allegranzi S Bonora S Vento E Concia, Acta Trop 1998 70 1 25 33 10.1016/S0001-706X(98)00010-2 9707362
41. Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum. MJV Le Jouan E Tetanye A Tran E Rey JM Treluyer M Tod G Pons, Antimicrob Agents Chemother 2005 49 9 3658 3662 10.1128/AAC.49.9.3658-3662.2005 16127036 (Pubitemid 41233014)
42. Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea. J Roche A Benito S Ayecaba C Amela R Molina J Alvar, Ann Trop Med Parasitol 1993 87 5 443 449 8311568 (Pubitemid 24002528)
43. Surveillance of in vivo resistance of Plasmodium falciparum to antimalarial drugs from 1992 to 1999 in Malabo (Equatorial Guinea). J Roche A Guerra-Neira J Raso A Benito, Am J Trop Med Hyg 2003 68 5 598 601 12812353 (Pubitemid 38240501)
44. Low-dose quinine is effective in the treatment of chloroquine-resistant Plasmodium falciparum malaria in eastern Sudan. MH Ibrahim MI Elbashir A Naser IA Aelbasit MM Kheir I Adam, Ann Trop Med Parasitol 2004 98 5 441 445 10.1179/000349804225003488 15257792 (Pubitemid 38951676)
45. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. J Achan JK Tibenderana D Kyabayinze F Wabwire Mangen MR Kamya G Dorsey U D'Alessandro PJ Rosenthal AO Talisuna, BMJ 2009 339 2763 10.1136/bmj.b2763 19622553
46. Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the Western Amazon region of Brazil. MG Alecrim MV Lacerda MP Mourao WD Alecrim A Padilha BS Cardoso M Boulos, Am J Trop Med Hyg 2006 74 1 20 25 16407341 (Pubitemid 46768625)
47. World Malaria Report 2009. WHO, 2009
48. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. BB Kangwana J Njogu B Wasunna SV Kedenge DN Memusi CA Goodman D Zurovac RW Snow, Am J Trop Med Hyg 2009 80 5 737 738 19407116
49. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. RS Miller C Wongsrichanalai N Buathong P McDaniel DS Walsh C Knirsch C Ohrt, Am J Trop Med Hyg 2006 74 3 401 406 16525097 (Pubitemid 46774360)
50. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. R McGready T Cho Samuel L Villegas A Brockman M van Vugt S Looareesuwan NJ White F Nosten, Trans R Soc Trop Med Hyg 2001 95 6 651 656 10.1016/S0035-9203(01)90106-3 11816439 (Pubitemid 34202258)
51. Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. P Parola S Ranque S Badiaga M Niang O Blin JJ Charbit J Delmont P Brouqui, Antimicrob Agents Chemother 2001 45 3 932 935 10.1128/AAC.45.3.932-935.2001 11181383 (Pubitemid 32182048)
52. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. H Noedl S Krudsood K Chalermratana U Silachamroon W Leowattana N Tangpukdee S Looareesuwan RS Miller M Fukuda K Jongsakul S Sriwichai J Rowan H Bhattacharyya C Ohrt C Knirsch, Clin Infect Dis 2006 43 10 1264 1271 10.1086/508175 17051490 (Pubitemid 44706451)
53. Low-dose quinine for treatment of chloroquine-resistant falciparum malaria in Sudanese pregnant women. I Adam MH Ibrahim IA Ae MI Elbashir, East Mediterr Health J 2004 10 4-5 554 559 16335646 (Pubitemid 41723439)
54. Clindamycin as an antimalarial drug: review of clinical trials. B Lell PG Kremsner, Antimicrob Agents Chemother 2002 46 8 2315 2320 10.1128/AAC.46.8. 2315-2320.2002 12121898 (Pubitemid 34793429)
55. Erythromycin and clindamycin absorption and elimination in pregnant women. A Philipson LD Sabath D Charles, Clin Pharmacol Ther 1976 19 1 68 77 1245094
56. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. R McGready EA Ashley E Moo T Cho M Barends R Hutagalung S Looareesuwan NJ White F Nosten, J Infect Dis 2005 192 5 846 853 10.1086/432551 16088834 (Pubitemid 41193082)
57. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. R McGready A Brockman T Cho D Cho M van Vugt C Luxemburger T Chongsuphajaisiddhi NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 6 689 693 10.1016/S0035-9203(00)90235-9 11198658
58. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs. NB Quashie NO Duah B Abuaku KA Koram, Ann Trop Med Parasitol 2007 101 5 391 398 10.1179/136485907X176553 17550644 (Pubitemid 47488127)
59. Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambarene, Gabon. AA Adegnika LP Breitling ST Agnandji SK Chai D Schutte S Oyakhirome NG Schwarz MP Grobusch MA Missinou M Ramharter S Issifou PG Kremsner, Am J Trop Med Hyg 2005 73 2 263 266 16103585 (Pubitemid 41278694)
60. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. P Piola C Nabasumba E Turyakira M Dhorda N Lindegardh D Nyehangane G Snounou EA Ashley R McGready F Nosten PJ Guerin, Lancet Infect Dis 2010 10 11 762 769 10.1016/S1473-3099(10)70202-4 20932805
61. Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. C Manyando R Mkandawire L Puma M Sinkala E Mpabalwani E Njunju M Gomes I Ribeiro V Walter M Virtanen R Schlienger M Cousin M Chipimo FM Sullivan, Malar J 2010 9 249 10.1186/1475-2875-9-249 20809964
62. Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. R Colebunders Y Bahwe W Nekwei R Ryder J Perriens K Nsimba A Turner H Francis I Lebughe P Van der Stuyft P Piot, J Infect 1990 21 2 167 173 10.1016/0163-4453(90)91701-E 2230175 (Pubitemid 20329684)
63. Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. AE Greenberg W Nsa RW Ryder M Medi M Nzeza N Kitadi M Baangi N Malanda F Davachi SE Hassig, N Engl J Med 1991 325 2 105 109 10.1056/NEJM199107113250206 2052043
64. Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers. JO Soyinka CO Onyeji SI Omoruyi AR Owolabi PV Sarma JM Cook, J Pharm Pharmacol 2009 61 4 439 443 19298689
65. Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration. JO Soyinka CO Onyeji SI Omoruyi AR Owolabi PV Sarma JM Cook, Br J Clin Pharmacol 2010 69 3 262 270 10.1111/j.1365-2125.2009.03566.x 20233197
66. Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man. S Wanwimolruk W Kang PF Coville S Viriyayudhakorn S Thitiarchakul, Br J Clin Pharmacol 1995 40 1 87 91 8527275
67. Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria. S Pukrittayakamee S Prakongpan S Wanwimolruk R Clemens S Looareesuwan NJ White, Antimicrob Agents Chemother 2003 47 5 1509 1513 10.1128/AAC.47.5.1509-1513.2003 12709315 (Pubitemid 36548530)
68. The potential for the interactions between antimalarial and antiretroviral drugs. S Khoo D Back P Winstanley, AIDS 2005 19 10 995 1005 10.1097/01.aids.0000174445.40379.e0 15958830 (Pubitemid 40961139)
69. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. AF Gasasira MR Kamya J Achan T Mebrahtu JN Kalyango T Ruel E Charlebois SG Staedke A Kekitiinwa PJ Rosenthal D Havlir G Dorsey, Clin Infect Dis 2008 46 7 985 991 10.1086/529192 18444813 (Pubitemid 351589861)
70. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. P German S Parikh J Lawrence G Dorsey PJ Rosenthal D Havlir E Charlebois W Hanpithakpong N Lindegardh FT Aweeka, J Acquir Immune Defic Syndr 2009 51 4 424 429 10.1097/QAI.0b013e3181acb4ff 19506482
71. High first dose quinine regimen for treating severe malaria. A Lesi M Meremikwu, Cochrane Database Syst Rev 2004 3 D003341
72. Artesunate versus quinine for treating severe malaria. KL Jones S Donegan DG Lalloo, Cochrane Database Syst Rev 2007 4 D005967
73. Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria. TE Taylor BA Wills JM Courval ME Molyneux, Trop Med Int Health 1998 3 1 3 8 10.1046/j.1365-3156.1998.00166.x 9484961 (Pubitemid 28081012)
74. A trial of artemether or quinine in children with cerebral malaria. MB van Hensbroek E Onyiorah S Jaffar G Schneider A Palmer J Frenkel G Enwere S Forck A Nusmeijer S Bennett B Greenwood D Kwiatkowski, N Engl J Med 1996 335 2 69 75 10.1056/NEJM199607113350201 8649492 (Pubitemid 26240107)
75. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. TA-QM-aS Group, Trans R Soc Trop Med Hyg 2001 95 6 637 650 11816438
76. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. JR Aceng JS Byarugaba JK Tumwine, BMJ 2005 330 7487 334 10.1136/bmj.330.7487.334 15705690
77. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. MF Gomes MA Faiz JO Gyapong M Warsame T Agbenyega A Babiker F Baiden EB Yunus F Binka C Clerk P Folb R Hassan MA Hossain O Kimbute A Kitua S Krishna C Makasi N Mensah Z Mrango P Olliaro R Peto TJ Peto MR Rahman I Ribeiro R Samad NJ White Study 13 Research Group, Lancet 2009 373 9663 557 566 10.1016/S0140-6736(08)61734-1 19059639
78. Case management of severe malaria - a forgotten practice: experiences from health facilities in Uganda. J Achan J Tibenderana D Kyabayinze H Mawejje R Mugizi B Mpeka A Talisuna U D'Alessandro, PLoS One 2011 6 3 17053 10.1371/journal.pone.0017053 21390301
79. Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial. J Achan J Byarugaba H Barennes JK Tumwine, Clin Infect Dis 2007 45 11 1446 1452 10.1086/522972 17990227 (Pubitemid 351411874)
80. [Intrarectal administration of quinine: an early treatment for severe malaria in children?]. H Barennes D Kailou E Pussard JM Munjakazi M Fernan H Sherouat A Sanda F Clavier F Verdier, Sante 2001 11 3 145 153 11641075 (Pubitemid 33000838)
81. [Rectal quinine, an alternative to parenteral injections for the treatment of childhood malaria. Clinical, parasitological and pharmacological study]. H Barennes D Kahiatani F Clavier D Meynard S Njifountawaouo F Barennes-Rasoanandrasana M Amadou M Soumana A Mahamansani G Granic F Verdier, Med Trop (Mars) 1995 55 4 Suppl 91 94 (Pubitemid 26163642)
82. Intrarectal Quinimax (an association of Cinchona alkaloids) for the treatment of Plasmodium falciparum malaria in children in Niger: efficacy and pharmacokinetics. H Barennes F Kahiatani E Pussard F Clavier D Meynard S Njifountawouo F Verdier, Trans R Soc Trop Med Hyg 1995 89 4 418 421 10.1016/0035-9203(95)90036-5 7570885
83. An open randomized clinical study of intrarectal versus infused Quinimax for the treatment of childhood cerebral malaria in Niger. H Barennes J Munjakazi F Verdier F Clavier E Pussard, Trans R Soc Trop Med Hyg 1998 92 4 437 440 10.1016/S0035-9203(98)91083-5 9850403 (Pubitemid 28409896)
84. Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial. H Barennes T Balima-Koussoube N Nagot JC Charpentier E Pussard, BMJ 2006 332 7549 1055 1059 10.1136/bmj.332.7549.1055 16675812
85. Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal. JL Ndiaye RC Tine B Faye HL Dieyeel PA Diack V Lameyre O Gaye HD Sow, Malar J 2007 6 152 10.1186/1475-2875-6-152 18005442
86. Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali. MA Thera F Keita MS Sissoko OB Traore D Coulibaly M Sacko V Lameyre JP Ducret O Doumbo, Malar J 2007 6 68 10.1186/1475-2875-6-68 17519031
87. A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria. F Esamai CN Tenge PO Ayuo WO Ong'or A Obala B Jakait, J Trop Pediatr 2005 51 1 17 24 10.1093/tropej/fmh069 15601653 (Pubitemid 40394188)
88. Antimalarial drug resistance: an increasing problem. W Peters, Br Med Bull 1982 38 2 187 192 7052200 (Pubitemid 12008190)
89. Chloroquine resistance of Plasmodium falciparum: a biological advantage? WH Wernsdorfer B Landgraf G Wiedermann H Kollaritsch, Trans R Soc Trop Med Hyg 1995 89 1 90 91 10.1016/0035-9203(95)90672-X 7747320
90. The epidemiology of drug-resistant malaria. A Bjorkman PA Phillips-Howard, Trans R Soc Trop Med Hyg 1990 84 2 177 180 10.1016/0035- 9203(90)90246-B 2202097 (Pubitemid 20171996)
91. In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos). M Mayxay M Barends A Brockman A Jaidee S Nair D Sudimack T Pongvongsa S Phompida R Phetsouvanh T Anderson NJ White PN Newton, Am J Trop Med Hyg 2007 76 2 245 250 17297031 (Pubitemid 351627769)
92. In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005. E Legrand B Volney JB Meynard O Mercereau-Puijalon P Esterre, Antimicrob Agents Chemother 2008 52 1 288 298 10.1128/AAC.00263-07 17954693
93. In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. H Tinto C Rwagacondo C Karema D Mupfasoni W Vandoren E Rusanganwa A Erhart C Van Overmeir E Van Marck U D'Alessandro, Trans R Soc Trop Med Hyg 2006 100 6 509 514 10.1016/j.trstmh.2005.09.018 16337665
94. [In vitro susceptibility of P. falciparum isolates from Abidjan (Cote d'Ivoire) to quinine, artesunate and chloroquine]. AO Toure LP Kone R Jambou TD Konan S Demba GE Beugre M Kone, Sante 2008 18 1 43 47 18684691
95. In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine. B Pradines M Mabika Mamfoumbi D Parzy M Owono Medang C Lebeau JR Mourou Mbina JC Doury M Kombila, Parasitology 1998 117 Pt 6 541 545 9881378 (Pubitemid 28552278)
96. Assessment of drug resistance to the malaria parasite in residents of Kampala, Uganda. LN Mutanda, East Afr Med J 1999 76 8 421 424 10520345
97. Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand. F Huttinger W Satimai G Wernsdorfer U Wiedermann K Congpuong WH Wernsdorfer, Wien Klin Wochenschr 2010 122 Suppl 3 52 56 20924699
98. A systematic overview of published antimalarial drug trials. HY Myint P Tipmanee F Nosten NP Day S Pukrittayakamee S Looareesuwan NJ White, Trans R Soc Trop Med Hyg 2004 98 2 73 81 10.1016/S0035-9203(03)00014-2 14964805 (Pubitemid 38111554)
99. In vivo and in vitro sensitivity of Falciparum malaria to quinine in Thai children. T Chongsuphajaisiddhi A Sabcharoen P Attanath, Ann Trop Paediatr 1981 1 1 21 26 6185041 (Pubitemid 12021263)
100. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. NJ White S Looareesuwan DA Warrell MJ Warrell D Bunnag T Harinasuta, Am J Med 1982 73 4 564 572 10.1016/0002-9343(82)90337-0 6751085 (Pubitemid 12003291)
101. Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment. S Looareesuwan P Charoenpan M Ho NJ White J Karbwang D Bunnag T Harinasuta, J Infect Dis 1990 161 3 577 580 10.1093/infdis/161.3.577 2179427 (Pubitemid 20107966)
102. Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations. PN Newton S Ward BJ Angus W Chierakul A Dondorp R Ruangveerayuth K Silamut P Teerapong Y Suputtamongkol S Looareesuwan NJ White, Trans R Soc Trop Med Hyg 2006 100 2 184 186 10.1016/j.trstmh.2005.01.008 16289166 (Pubitemid 43024775)
103. Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. S Pukrittayakamee S Wanwimolruk K Stepniewska A Jantra S Huyakorn S Looareesuwan NJ White, Antimicrob Agents Chemother 2003 47 11 3458 3463 10.1128/AAC.47.11.3458-3463.2003 14576102 (Pubitemid 37345704)
104. Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. O Onwujekwe H Kaur N Dike E Shu B Uzochukwu K Hanson V Okoye P Okonkwo, Malar J 2009 8 22 10.1186/1475-2875-8-22 19208221
105. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials. MC Gaudiano A Di Maggio E Cocchieri E Antoniella P Bertocchi S Alimonti L Valvo, Malar J 2007 6 22 10.1186/1475-2875-6-22 17316432
106. Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. LK Basco, Am J Trop Med Hyg 2004 70 5 474 480 15155978 (Pubitemid 38658140)
107. Counterfeit and substandard antimalarial drugs in Cambodia. CT Lon R Tsuyuoka S Phanouvong N Nivanna D Socheat C Sokhan N Blum EM Christophel A Smine, Trans R Soc Trop Med Hyg 2006 100 11 1019 1024 10.1016/j.trstmh.2006.01. 003 16765399 (Pubitemid 44334726)
108. The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution. PC Kayumba PG Risha D Shewiyo A Msami G Masuki D Ameye G Vergote JD Ntawukuliryayo JP Remon C Vervaet, J Clin Pharm Ther 2004 29 4 331 338 10.1111/j.1365-2710.2004.00568.x 15271100 (Pubitemid 39062163)
109. High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic. W Metzger B Mordmuller W Graninger U Bienzle PG Kremsner, Antimicrob Agents Chemother 1995 39 1 245 246 7695315